tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:MOL Stock Latest News

Moleculin Biotech trading halted, news pending
The FlyMoleculin Biotech trading halted, news pending
3M ago
MBRX
Moleculin Biotech Announces Reverse Stock Split
PremiumCompany Announcements
Moleculin Biotech Announces Reverse Stock Split
3M ago
8K
MBRX
Moleculin Biotech announces 1-for-25 reverse stock split
PremiumThe Fly
Moleculin Biotech announces 1-for-25 reverse stock split
3M ago
MBRX
Moleculin Biotech Releases Corporate Presentation Update
PremiumCompany Announcements
Moleculin Biotech Releases Corporate Presentation Update
3M ago
8K
MBRX
Moleculin Biotech Appeals Nasdaq Delisting Decision
PremiumCompany Announcements
Moleculin Biotech Appeals Nasdaq Delisting Decision
3M ago
8K
MBRX
MBRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMBRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
MBRX
Moleculin Biotech Reports Increased Loss Amid Ongoing Trials
Premium
Company Announcements
Moleculin Biotech Reports Increased Loss Amid Ongoing Trials
3M ago
MBRX
Moleculin Biotech Advances Annamycin Phase 2B/3 Study
Premium
Company Announcements
Moleculin Biotech Advances Annamycin Phase 2B/3 Study
3M ago
8K
MBRX
Moleculin Biotech reports 60% of first 45 subjects in ‘MIRCALE’ Phase 3 trial
PremiumThe Fly
Moleculin Biotech reports 60% of first 45 subjects in ‘MIRCALE’ Phase 3 trial
3M ago
MBRX
Moleculin Biotech’s Strategic Advancements and Potential in Oncology: Buy Rating Justified by Key Partnerships and Promising Trials
PremiumRatings
Moleculin Biotech’s Strategic Advancements and Potential in Oncology: Buy Rating Justified by Key Partnerships and Promising Trials
3M ago
MBRX
Moleculin Biotech Partners with UNC for Cancer Research
PremiumCompany Announcements
Moleculin Biotech Partners with UNC for Cancer Research
3M ago
8K
MBRX
Moleculin Biotech announces grant funded research evaluating Annamycin
PremiumThe Fly
Moleculin Biotech announces grant funded research evaluating Annamycin
3M ago
MBRX
Moleculin Biotech Releases New Corporate Presentation
PremiumCompany AnnouncementsMoleculin Biotech Releases New Corporate Presentation
4M ago
8K
MBRX
Moleculin Biotech Secures Australian Patent for Annamycin
Premium
Company Announcements
Moleculin Biotech Secures Australian Patent for Annamycin
4M ago
8K
MBRX
Moleculin Biotech announces new Australian patent for Annamycin
Premium
The Fly
Moleculin Biotech announces new Australian patent for Annamycin
4M ago
MBRX
Promising Developments in Moleculin Biotech’s Annamycin Drive Buy Rating
PremiumRatings
Promising Developments in Moleculin Biotech’s Annamycin Drive Buy Rating
4M ago
MBRX
Moleculin Biotech’s Promising Drug Pipeline and Strategic Expansion Justify Buy Rating
PremiumRatings
Moleculin Biotech’s Promising Drug Pipeline and Strategic Expansion Justify Buy Rating
4M ago
MBRX
Moleculin Biotech Partners with Atlantic Health System
PremiumCompany Announcements
Moleculin Biotech Partners with Atlantic Health System
4M ago
8K
MBRX
Moleculin Biotech works with Atlantic Health on Phase 1B/2 study of Annamycin
PremiumThe Fly
Moleculin Biotech works with Atlantic Health on Phase 1B/2 study of Annamycin
4M ago
MBRX
Moleculin Biotech Stockholders Approve Share Issuance
PremiumCompany AnnouncementsMoleculin Biotech Stockholders Approve Share Issuance
4M ago
8K
MBRX
Moleculin Biotech Secures Canadian Patent for Annamycin
Premium
Company Announcements
Moleculin Biotech Secures Canadian Patent for Annamycin
5M ago
8K
MBRX
Moleculin Biotech announces issuance of Canadian patent covering Annamycin
Premium
The Fly
Moleculin Biotech announces issuance of Canadian patent covering Annamycin
5M ago
MBRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >